Robert Salisbury - Director, Enzon Pharmaceuticals Inc

As of January 4, 2013


Robert Salisbury Net Worth

  • Net worth is estimated to be at least $2.77K
  • Owns at least 35,161 units of Enzon Pharmaceuticals Inc stock
  • Sold an estimated value of $13.1K in the last 8 years at Enzon Pharmaceuticals Inc

Robert Salisbury Trading

  • Largest purchase of shares was 5,970 units , worth over $19.11K on November 14, 2008
  • Largest sale of shares was 4,030 units , worth over $13.1K on November 14, 2008
  • In total has made about 17 transactions over 8 years
  • Usually trades in January, with the busiest year in 2008
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Enzon Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 107,500 units sold on August 17, 2021 by Jonathan Couchman, Couchman Family Fund, Xstelos Corp and Myrexis Inc worth over $41.9K
  • In the last 17 years, insiders at Enzon Pharmaceuticals Inc sold an estimated value of $14.67M and bought an estimated value of $10.97M
  • The most active traders are Robert Lebuhn, Director,  Ivan Horak, EVP,  and Craig A Tooman, Exec VP Finance
  • Insider trading is most common in January, with the busiest year in 2010

ENZON PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1